Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jan 13, 2018
Finance
Choosy investors
...SSE:BIOA B) 10/12/17 $85.9 $216.9 $232.9 7% OptiNose Inc. (NASDAQ:OPTN) 10/12/17 $138.0 $604.2 $714.8 18%
Biom'Up S.A.
...
Read More
BioCentury
|
Oct 6, 2017
Finance
High as a Kite
...$86.3M Ph I Cue Biopharma Inc. 9/21/17 $37.5M Preclin OptiNose Inc. 9/18/17 $100M Approved (drug)
Biom'Up S.A.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jan 13, 2018
Finance
Choosy investors
...SSE:BIOA B) 10/12/17 $85.9 $216.9 $232.9 7% OptiNose Inc. (NASDAQ:OPTN) 10/12/17 $138.0 $604.2 $714.8 18%
Biom'Up S.A.
...
Read More
BioCentury
|
Oct 6, 2017
Finance
High as a Kite
...$86.3M Ph I Cue Biopharma Inc. 9/21/17 $37.5M Preclin OptiNose Inc. 9/18/17 $100M Approved (drug)
Biom'Up S.A.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page
